Patent Yard Sign in
European application, no grantEurope

A process for the production of human interferon alpha from genetically engineered yeast

EP 1272624 A1 · Applicant: Shantha Biotechnics (P) Ltd

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 16, 2000 and never granted as a European patent. Had it been granted, its 20-year term would have ended March 16, 2020.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 16, 2025.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 16, 2000
PublishedJanuary 8, 2003
GrantedNever granted
Term endedMarch 16, 2020
Application numberEP 00909584
Classification (CPC)C07K14/56

Timeline

Timeline From EPO dates

2001200320052007200920112013201520172019Application filedMarch 16, 2000PublishedJan 8, 2003Term endedMarch 16, 2020

Sources & verification